Product NDC: | 65862-596 |
Proprietary Name: | Clindamycin Palmitate Hydrochloride (Pediatric) |
Non Proprietary Name: | Clindamycin Palmitate Hydrochloride (Pediatric) |
Active Ingredient(s): | 75 mg/5mL & nbsp; Clindamycin Palmitate Hydrochloride (Pediatric) |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-596 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202409 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130430 |
Package NDC: | 65862-596-01 |
Package Description: | 1 BOTTLE in 1 CARTON (65862-596-01) > 100 mL in 1 BOTTLE |
NDC Code | 65862-596-01 |
Proprietary Name | Clindamycin Palmitate Hydrochloride (Pediatric) |
Package Description | 1 BOTTLE in 1 CARTON (65862-596-01) > 100 mL in 1 BOTTLE |
Product NDC | 65862-596 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clindamycin Palmitate Hydrochloride (Pediatric) |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20130430 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
Strength Number | 75 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |